Duke-NUS Emerging Infectious Disease Program (EID)
EID has played key roles in supporting the national response to the COVID-19 pandemic which includes early isolation and swift characterization of SARS-CoV-2, the development of the world’s first surrogate viral neutralization test, surveillance, diagnostics, vaccines and cutting-edge efforts to investigate potential treatments. EID also houses the Satellite Centre for Global Health Discovery, which is a J&J and Duke-NUS joint effort to discover therapeutics against flaviviruses. Additional research stretching back decades has focused on better understanding risk factors for pandemic emergence including diagnostics and disease surveillance in humans and animals at key interfaces (bat, rats and pigs with humans) to assess the regional prevalence and distribution of pathogens in Cambodia, India, Lao, Malaysia, Philippines, Thailand, Vietnam